Citation Tools
PDFRegular and young investigator award abstracts
Clinical trials completed
265 Phase 1b study of avelumab + M9241 (NHS-IL12) in patients with advanced solid tumors: interim analysis results from a urothelial carcinoma (UC) dose-expansion cohort
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 265 Phase 1b study of avelumab + M9241 (NHS-IL12) in patients with advanced solid tumors: interim analysis results from a urothelial carcinoma (UC) dose-expansion cohort